Skip to content

Longitudinal Study of Patient Economic Toxicity in Solid Tumor Clinical Research Using User Profiling

Longitudinal Study of Patient Economic Toxicity in Solid Tumor Clinical Research Using User Profiling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118830
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-23
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumor

Interventions

Observation group:none

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Diagnosed with a solid malignant tumor by histopathology; 3. Has officially signed the informed consent form and entered the clinical trial treatment phase, and is able to complete at least six cycles of treatment as required by the clinical trial protocol; 4. Clear consciousness, possesses basic communication skills, and can understand and complete questionnaires and interviews; 5. Voluntarily participates in this study and signs the informed consent form specifically for this research.

Exclusion criteria

Exclusion criteria: 1. The condition is critical and unable to endure participation; 2. Presence of mental illness or cognitive impairment prevents cooperation with completing the questionnaire; 3. Severe visual or hearing impairment, or communication disorders, assessed as unable to complete the survey; 4. Individuals who refuse to participate.

Design outcomes

Primary

MeasureTime frame
financial toxicity;

Secondary

MeasureTime frame
Medical coping styles;

Countries

China

Contacts

Public ContactShanshan Wu

The First Affiliated Hospital with Nanjing Medical University

1249887328@qq.com+86 159 5183 1828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026